Trial Profile

Phase-III Comparative Study of EVA-001 for Osteoarthritis of the Knee

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 04 Jun 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs SMUP-IA-01 (Primary)
Indications Osteoarthritis
Focus Registrational; Therapeutic Use
Sponsors Medipost

Most Recent Events

14 May 2026 According to a Medipost media release, trial was conducted at the 13 sites in Japan.
14 May 2026 According to a Medipost media release, based on results from this study the company to file BLA in Japan in 2H 2026 later this year targeting regulatory approval by end of 2027.
14 May 2026 Primary endpoint has been met. (2) Percentage of improvement in ICRS grade 1 or better at 52 weeks post-treatment), according to Medipost Media Release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com